Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
43.42 USD | +0.96% | +3.50% | -14.40% |
Apr. 11 | North American Morning Briefing : Stock Futures -2- | DJ |
Apr. 10 | Wolfe Research Upgrades Ionis Pharmaceuticals to Outperform From Peer Perform | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.40% | 6.27B | |
+22.33% | 42.68B | |
-3.37% | 42.4B | |
+45.32% | 40.04B | |
-6.20% | 28.31B | |
+8.30% | 24.94B | |
-19.77% | 18.96B | |
+29.71% | 12.3B | |
-2.98% | 11.95B | |
-1.87% | 11.55B |
- Stock Market
- Equities
- IONS Stock
- News Ionis Pharmaceuticals, Inc.
- Ionis Pharmaceuticals Says Potential Angioedema Treatment Met Primary Endpoint of Phase 3 Study